Mechanisms of resistance to TRAIL-induced apoptosis in cancer
Lidong Zhang,
B. Fang
|
9 |
2005 |
9
2005
|
Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms
Rong En Tay,
E. Richardson,
H. Toh
|
9 |
2020 |
9
2020
|
Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma
8 auth.
M. Mastrangelo,
H. Maguire,
L. Eisenlohr,
Carol E. Laughlin,
C. Monken,
P. Mccue,
...
A. Kovatich,
E. Lattime
|
8 |
1999 |
8
1999
|
The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53, and fibronectin
V. Baron,
E. Adamson,
A. Calogero,
G. Ragona,
D. Mercola,
D. Mercola
|
8 |
2006 |
8
2006
|
siRNA-based approaches in cancer therapy
G. Devi
|
8 |
2006 |
8
2006
|
A comparison of gene transfer methods in human dendritic cells.
10 auth.
J. Arthur,
L. Butterfield,
Michael Roth,
L. Bui,
S. Kiertscher,
R. Lau,
...
S. Dubinett,
J. Glaspy,
W. McBride,
J. Economou
|
8 |
1997 |
8
1997
|
Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients
10 auth.
J. Nemunaitis,
C. Cunningham,
N. Senzer,
J. Kuhn,
Jennifer Cramm,
Craig Litz,
...
R. Cavagnolo,
A. Cahill,
C. Clairmont,
M. Sznol
|
8 |
2003 |
8
2003
|
MicroRNA and drug resistance
J. Ma,
C. Dong,
C. Ji
|
8 |
2010 |
8
2010
|
Key chemokines direct migration of immune cells in solid tumors
Karan Kohli,
V. Pillarisetty,
Teresa S. Kim
|
8 |
2021 |
8
2021
|
High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus.
Wei-wei Zhang,
Xianjun Fang,
Wojciech Mazur,
B. A. French,
R. Georges,
J. Roth
|
8 |
1994 |
8
1994
|
MicroRNA profile analysis of human prostate cancers
10 auth.
A. Tong,
P. Fulgham,
C. Jay,
Patrick Chen,
I. Khalil,
Shengnan Liu,
...
N. Senzer,
A. Eklund,
J. Han,
J. Nemunaitis
|
8 |
2009 |
8
2009
|
Intravascular adenoviral agents in cancer patients: Lessons from clinical trials
T. Reid,
R. Warren,
D. Kirn
|
8 |
2002 |
8
2002
|
Oncolytic herpes simplex virus vectors for cancer virotherapy
S. Varghese,
S. Rabkin
|
8 |
2002 |
8
2002
|
Role of anti-oncomirs miR-143 and -145 in human colorectal tumors
10 auth.
Y. Akao,
Y. Akao,
Yoshihito Nakagawa,
Ichiro Hirata,
A. Iio,
T. Itoh,
...
Keitaro Kojima,
Remi Nakashima,
Yukio Kitade,
T. Naoe
|
8 |
2010 |
8
2010
|
Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?
Alex W. Tong,
J. Nemunaitis
|
7 |
2008 |
7
2008
|
The ERBB3 receptor in cancer and cancer gene therapy
G. Sithanandam,
LM Anderson
|
7 |
2008 |
7
2008
|
